High-flow Nasal Oxygenation During Deep Sedation in Pediatric Dental Patients
NCT ID: NCT05762692
Last Updated: 2023-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2023-06-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Flow Nasal Oxygen Therapy in Pediatric Hypercapnic Respiratory Failure During Perioperative Stage
NCT03534960
Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients
NCT04852432
Retrospective Study on Prolonged Sedation Effects With Inhaled Agents in PICU
NCT05064592
Effect of High-flow Nasal Oxygenation on Gastric Insufflation in Children
NCT06204653
High Flow Nasal Cannula for Safe Apnea
NCT04849520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFNO Group
Intra-operative oxygenation will be administered by the high-flow nasal oxygenation device. The flow rate is 2L/kg.(upper limit 30L/min)
High-flow nasal oxygenation device
The patients included will be oxygenated by HFNO device during the operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-flow nasal oxygenation device
The patients included will be oxygenated by HFNO device during the operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. anticipated operation time over 60 mins.
Exclusion Criteria
2. Any contraindications of high flow nasal oxygenation.
3. Any contraindications or allergic history of propofol.
3 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yang Xudong
Chief of Department of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University of Stomatology
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xudong Yang
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKUSSIRB-202283174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.